Update of the Adult and Pediatric Liver Transplant Program at the University of Michigan.

J. G. Turcotte, J. C. Magee, J. S. Bromberg, D. A. Campbell, C. J. Dickinson, R. J. Fontana, K. S. Henley, A. C. Hillemeier, A. S. Lok, K. S. Lown, A. D. Olson, J. D. Punch, G. L. Su, R. M. Merion

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Significant technical innovations and improvements in immunosuppression have been introduced into our liver transplant program since its inception in 1985. The indications for transplantation have been extended to younger and older patients, and simultaneously more patients with comorbidities have been accepted for transplant. The net impact of these changes has been a continuing trend toward improved survival. Overall, patients with hepatitis B or malignancy have had poor survival rates. The introduction of prophylactic anti-hepatitis B immunoglobulin and lamivudine, and better selection of patients with malignancy may improve results for these patients in the future. As in other programs, our most vexing problem is the continuing scarcity of donor organs which has led to an ever-expanding waiting list, more deaths while awaiting transplant, and more suffering before transplantation. The introduction of living donor hepatic transplantation will be of some help in alleviating this shortage. We are confident that the evolution of our program into a joint multidisciplinary structure will provide more efficient, convenient and cost-effective care to our patients.

Original languageEnglish (US)
Pages (from-to)203-216
Number of pages14
JournalClinical transplants
StatePublished - Jan 1 1996

Fingerprint

Pediatrics
Transplants
Liver
Hepatitis B
Transplantation
Lamivudine
Waiting Lists
Living Donors
Psychological Stress
Liver Transplantation
Immunosuppression
Patient Selection
Comorbidity
Immunoglobulins
Neoplasms
Survival Rate
Joints
Tissue Donors
Costs and Cost Analysis
Survival

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Turcotte, J. G., Magee, J. C., Bromberg, J. S., Campbell, D. A., Dickinson, C. J., Fontana, R. J., ... Merion, R. M. (1996). Update of the Adult and Pediatric Liver Transplant Program at the University of Michigan. Clinical transplants, 203-216.
Turcotte, J. G. ; Magee, J. C. ; Bromberg, J. S. ; Campbell, D. A. ; Dickinson, C. J. ; Fontana, R. J. ; Henley, K. S. ; Hillemeier, A. C. ; Lok, A. S. ; Lown, K. S. ; Olson, A. D. ; Punch, J. D. ; Su, G. L. ; Merion, R. M. / Update of the Adult and Pediatric Liver Transplant Program at the University of Michigan. In: Clinical transplants. 1996 ; pp. 203-216.
@article{252cf9dcc7d14aae9fc1a70bfa070ffe,
title = "Update of the Adult and Pediatric Liver Transplant Program at the University of Michigan.",
abstract = "Significant technical innovations and improvements in immunosuppression have been introduced into our liver transplant program since its inception in 1985. The indications for transplantation have been extended to younger and older patients, and simultaneously more patients with comorbidities have been accepted for transplant. The net impact of these changes has been a continuing trend toward improved survival. Overall, patients with hepatitis B or malignancy have had poor survival rates. The introduction of prophylactic anti-hepatitis B immunoglobulin and lamivudine, and better selection of patients with malignancy may improve results for these patients in the future. As in other programs, our most vexing problem is the continuing scarcity of donor organs which has led to an ever-expanding waiting list, more deaths while awaiting transplant, and more suffering before transplantation. The introduction of living donor hepatic transplantation will be of some help in alleviating this shortage. We are confident that the evolution of our program into a joint multidisciplinary structure will provide more efficient, convenient and cost-effective care to our patients.",
author = "Turcotte, {J. G.} and Magee, {J. C.} and Bromberg, {J. S.} and Campbell, {D. A.} and Dickinson, {C. J.} and Fontana, {R. J.} and Henley, {K. S.} and Hillemeier, {A. C.} and Lok, {A. S.} and Lown, {K. S.} and Olson, {A. D.} and Punch, {J. D.} and Su, {G. L.} and Merion, {R. M.}",
year = "1996",
month = "1",
day = "1",
language = "English (US)",
pages = "203--216",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

Turcotte, JG, Magee, JC, Bromberg, JS, Campbell, DA, Dickinson, CJ, Fontana, RJ, Henley, KS, Hillemeier, AC, Lok, AS, Lown, KS, Olson, AD, Punch, JD, Su, GL & Merion, RM 1996, 'Update of the Adult and Pediatric Liver Transplant Program at the University of Michigan.', Clinical transplants, pp. 203-216.

Update of the Adult and Pediatric Liver Transplant Program at the University of Michigan. / Turcotte, J. G.; Magee, J. C.; Bromberg, J. S.; Campbell, D. A.; Dickinson, C. J.; Fontana, R. J.; Henley, K. S.; Hillemeier, A. C.; Lok, A. S.; Lown, K. S.; Olson, A. D.; Punch, J. D.; Su, G. L.; Merion, R. M.

In: Clinical transplants, 01.01.1996, p. 203-216.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Update of the Adult and Pediatric Liver Transplant Program at the University of Michigan.

AU - Turcotte, J. G.

AU - Magee, J. C.

AU - Bromberg, J. S.

AU - Campbell, D. A.

AU - Dickinson, C. J.

AU - Fontana, R. J.

AU - Henley, K. S.

AU - Hillemeier, A. C.

AU - Lok, A. S.

AU - Lown, K. S.

AU - Olson, A. D.

AU - Punch, J. D.

AU - Su, G. L.

AU - Merion, R. M.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Significant technical innovations and improvements in immunosuppression have been introduced into our liver transplant program since its inception in 1985. The indications for transplantation have been extended to younger and older patients, and simultaneously more patients with comorbidities have been accepted for transplant. The net impact of these changes has been a continuing trend toward improved survival. Overall, patients with hepatitis B or malignancy have had poor survival rates. The introduction of prophylactic anti-hepatitis B immunoglobulin and lamivudine, and better selection of patients with malignancy may improve results for these patients in the future. As in other programs, our most vexing problem is the continuing scarcity of donor organs which has led to an ever-expanding waiting list, more deaths while awaiting transplant, and more suffering before transplantation. The introduction of living donor hepatic transplantation will be of some help in alleviating this shortage. We are confident that the evolution of our program into a joint multidisciplinary structure will provide more efficient, convenient and cost-effective care to our patients.

AB - Significant technical innovations and improvements in immunosuppression have been introduced into our liver transplant program since its inception in 1985. The indications for transplantation have been extended to younger and older patients, and simultaneously more patients with comorbidities have been accepted for transplant. The net impact of these changes has been a continuing trend toward improved survival. Overall, patients with hepatitis B or malignancy have had poor survival rates. The introduction of prophylactic anti-hepatitis B immunoglobulin and lamivudine, and better selection of patients with malignancy may improve results for these patients in the future. As in other programs, our most vexing problem is the continuing scarcity of donor organs which has led to an ever-expanding waiting list, more deaths while awaiting transplant, and more suffering before transplantation. The introduction of living donor hepatic transplantation will be of some help in alleviating this shortage. We are confident that the evolution of our program into a joint multidisciplinary structure will provide more efficient, convenient and cost-effective care to our patients.

UR - http://www.scopus.com/inward/record.url?scp=0030321523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030321523&partnerID=8YFLogxK

M3 - Article

C2 - 9286569

AN - SCOPUS:0030321523

SP - 203

EP - 216

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -

Turcotte JG, Magee JC, Bromberg JS, Campbell DA, Dickinson CJ, Fontana RJ et al. Update of the Adult and Pediatric Liver Transplant Program at the University of Michigan. Clinical transplants. 1996 Jan 1;203-216.